Home › Attention Deficit Hyperactivity Disorder › Tennessee
Attention Deficit Hyperactivity Disorder clinical trials in Tennessee
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in Tennessee.
Cities in Tennessee
Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
- Clinical Neuroscience Solutions, Inc., Memphis
RecruitingPhase 4
48 Months – 69 Months · All sexes · Updated Sep 11, 2026 · NCT04781140Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease
- St. Jude Children's Research Hospital, Memphis
RecruitingPhase 1
Ages 8 to 17 · All sexes · Updated Sep 9, 2026 · NCT07226219Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Clinical Research Site, Memphis
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 8, 2026 · NCT07717892Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Clinical Research Site, Memphis
RecruitingPhase 3
Ages 6 to 11 · All sexes · Updated Sep 8, 2026 · NCT07717879From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.